Krug, D., Vonthein, R., Schreiber, A., Boicev, A. D., Zimmer, J., Laubach, R., . . . Dunst, J. (2021). Impact of guideline changes on adoption of hypofractionation and breast cancer patient characteristics in the randomized controlled HYPOSIB trial. Strahlentherapie und Onkologie, 197(9), . https://doi.org/10.1007/s00066-020-01730-9
Chicago-Zitierstil (17. Ausg.)Krug, David, et al. "Impact of Guideline Changes on Adoption of Hypofractionation and Breast Cancer Patient Characteristics in the Randomized Controlled HYPOSIB Trial." Strahlentherapie Und Onkologie 197, no. 9 (2021). https://doi.org/10.1007/s00066-020-01730-9.
MLA-Zitierstil (9. Ausg.)Krug, David, et al. "Impact of Guideline Changes on Adoption of Hypofractionation and Breast Cancer Patient Characteristics in the Randomized Controlled HYPOSIB Trial." Strahlentherapie Und Onkologie, vol. 197, no. 9, 2021, https://doi.org/10.1007/s00066-020-01730-9.